UK microbiome firm Microbiotica has completed a €60m (£50m) financing round intended to fund its two lead oral live biotherapeutics (LBP) developed to tackle Ulcerative Colitis (UC).
Alterations in gut microbiota composition are associated with metabolic syndrome and chronic inflammatory diseases such as inflammatory bowel disease. Researchers recently investigated whether elicitation of anti-flagellin antibodies might serve as a...
The number of people suffering from inflammatory bowel diseases (IBD) is three times higher than previous estimates, with sufferers also at a higher risk of developing colorectal cancer (CRC), according to new research.
DISPATCHES FROM IPA WORLD CONGRESS + PROBIOTA 2018
Ger Rijkers’ snapshot of how probiotics research is shaping up across the world is perhaps a glimpse into future scientific discoveries as well as product development opportunities they could give rise to.
Bristol-Myers Squibb and Principia SGR join existing investors including Nestlé Health Science and Seventure
French biotech Enterome will step up its development of microbiome-based clinical therapeutics for IBD and cancer after raising €32 million in Series D Financing.
Israel-based microbiome firm BiomX says the acquisition of RondinX will fortify the company’s bacterial target discovery capabilities and supports its product development pipeline.
Low vitamin D levels may reduce the chances of success of treatment for inflammatory bowel diseases (IBD) such as colitis and Crohn’s, according to a new study.
Aluminium is likely to harm gut homeostasis as increased exposure is strongly linked to inflammatory bowel disease (IBD) as an environmental risk factor, a review has concluded.
An extract from fucoidans may provide promise for treating a type of inflammatory bowel disease known as ulcerative colitis, a new study published in PLoS One suggests.
Vitamin D may modify the immune response in people with inflammatory bowel disease (IBD), according to a review of evidence for vitamin D as a novel therapy for the condition.
Compounds extracted from apple peel may influence expression of a key inflammatory gene, suggests new data from Germany with potential implications for IBD.
Scientists have identified the gut microbial pattern that corresponds with excess body weight, and deepen our understanding of how the gut microflora interacts with host metabolism.
Nutraceutical developer Provexis says it is in advanced discussions
over exiting its demonstration juice brand Sirco to focus on the
future, as it reports strong sales and a reduction in its operating
loss in the full year ended March...
Advitech, the maker of psoriasis nutraceutical Dermylex, has
announced the signing of a definitive agreement with Enbio-Life
Biotech and Medical Company for distribution in Taiwan - the latest
development in the oral supplement's...
Children and adolescents with inflammatory bowel disease (IBD) are
at an increased risk of vitamin D deficiency and could benefit from
supplements to avoid the health problems associated with not
getting enough of the vitamin.
Advitech, the maker of psoriasis nutraceutical Dermylex has
announced it is signing on a former Canadian Olympian to promote
its whey-derived ingredient - this is the latest in a series of
announcements as the company plugs the oral...
HortResearch has seen positive results on how apple extracts impact
genes associated with Crohn's disease as part of a collaboration to
understand how food and disease are linked at a molecular genetic
level.
Advitech looks set to add another string to the bow of uses for its
XP-828L platform with good preliminary results from a study
assessing its effects on atopic dermatitis, while unexpected demand
for Dermylex for psoriasis has necessitated...
A UK nutraceutical firm is hoping to develop an extract of the
plaintain banana as a medical food, after initial research shows it
could treat inflammatory bowel disease, such as Crohn's disease,
writes Dominique Patton.
